These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 10983617
41. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Pedersen B, Dahl R, Karlström R, Peterson CG, Venge P. Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596 [Abstract] [Full Text] [Related]
42. Eosinophil soluble protein levels, eosinophil peroxidase and eosinophil cationic protein in asthmatic patients. Parra A, Sanz ML, Vila L, Prieto I, Diéguez I, Oehling AK. J Investig Allergol Clin Immunol; 1999 May; 9(1):27-34. PubMed ID: 10212854 [Abstract] [Full Text] [Related]
43. [Eosinophil cationic protein in patients with bronchial asthma]. Numao T, Fukuda T, Hirata A, Sagara H, Majima K, Nakajima H, Akutsu I, Ando N, Makino S. Arerugi; 1991 Feb; 40(2):93-9. PubMed ID: 1712583 [Abstract] [Full Text] [Related]
44. [Effect of triamcinolone acetonide, montelukast, nedocromil sodium and formoterol on eosinophil blood counts, ECP serum levels and clinical progression of asthma in children]. Stelmach I, Grzelewski T, Stelmach W, Majak P, Jerzyńska J, Górski P, Kuna P. Pol Merkur Lekarski; 2002 Mar; 12(69):208-13. PubMed ID: 12053590 [Abstract] [Full Text] [Related]
45. Does eosinophil cationic protein in sputum and blood reflect bronchial inflammation and obstruction in allergic asthmatics? Grebski E, Wu J, Wüthrich B, Medici TC. J Investig Allergol Clin Immunol; 1999 Mar; 9(2):82-8. PubMed ID: 10353094 [Abstract] [Full Text] [Related]
46. Serum measurement of eosinophil cationic protein in the management of asthma. Niimi A, Matsumoto H. Curr Opin Pulm Med; 1999 Mar; 5(2):111-7. PubMed ID: 10813261 [Abstract] [Full Text] [Related]
47. Eosinophil activity reflects clinical status in patients with asthma before and during a prednisolone course. Skedinger M, Halldén G, Lundahl J, Hed J, Zetterström O. Ann Allergy Asthma Immunol; 1995 Sep; 75(3):250-5. PubMed ID: 7552927 [Abstract] [Full Text] [Related]
48. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma. Strauch E, Moske O, Thoma S, Storm Van's Gravesande K, Ihorst G, Brandis M, Kuehr J. Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396 [Abstract] [Full Text] [Related]
49. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Zimmerman B, Lanner A, Enander I, Zimmerman RS, Peterson CG, Ahlstedt S. Clin Exp Allergy; 1993 Jul; 23(7):564-70. PubMed ID: 8221257 [Abstract] [Full Text] [Related]
52. [Eosinophil count in induced sputum samples as a marker of airway inflammation and adequacy of corticosteroid inhalation treatment in asthmatic patients]. Tomii K, Matsumura Y, Taguchi Y, Oida K, Kobash Y. Nihon Kokyuki Gakkai Zasshi; 1998 Feb; 36(2):138-43. PubMed ID: 9617140 [Abstract] [Full Text] [Related]
53. [Eosinophil cationic protein in serum from adults with asthma and with chronic obstructive pulmonary disease]. Yoshizawa A, Kamimura M, Sugiyama H, Kudo K, Kabe J. Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jan; 34(1):24-9. PubMed ID: 8717287 [Abstract] [Full Text] [Related]
54. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow]. Nakazawa T, Kagami M, Matumura R, Kawashima T, Matuzuwa Y, Takada M. Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401 [Abstract] [Full Text] [Related]
55. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma. Stelmach I, Jerzynska J, Kuna P. Clin Exp Allergy; 2002 Feb; 32(2):264-9. PubMed ID: 11929492 [Abstract] [Full Text] [Related]
56. Eosinophil activation markers in induced sputum in asthmatics. Jang AS, Choi IS. Korean J Intern Med; 2000 Jan; 15(1):1-7. PubMed ID: 10714084 [Abstract] [Full Text] [Related]
57. Comparison of the effects of salmeterol and salbutamol on clinical activity and eosinophil cationic protein serum levels during the pollen season in atopic asthmatics. Di Lorenzo G, Morici G, Norrito F, Mansueto P, Melluso M, Purello D'Ambrosio F, Barbagallo Sangiorgi G. Clin Exp Allergy; 1995 Oct; 25(10):951-6. PubMed ID: 8556566 [Abstract] [Full Text] [Related]
58. [Inflammation mediators (eosinophilic cationic protein, ECP) in a normal population and in patients with bronchial asthma or allergic rhinitis]. Alvarez Gutiérrez FJ, Rodríguez Portal JA, Valenzuela Mateos F, Capote Gil F, Sánchez Gil R, Castillo Gómez J. Arch Bronconeumol; 1995 Oct; 31(6):280-6. PubMed ID: 7627423 [Abstract] [Full Text] [Related]
59. Intracellular expression and serum levels of eosinophil peroxidase (EPO) and eosinophil cationic protein in asthmatic children. Krug N, Napp U, Enander I, Eklund E, Rieger CH, Schauer U. Clin Exp Allergy; 1999 Nov; 29(11):1507-15. PubMed ID: 10520079 [Abstract] [Full Text] [Related]
60. One-year evaluation of the preventative effect of hydrofluoroalkane-beclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways. Ohbayashi H. Respiration; 2007 Nov; 74(2):146-53. PubMed ID: 16804291 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]